A model for decision support in signal triage

Drug Safety

Volumn 31, Issue 9, 2008, Pages 727-735

  Levitan, Bennett ^a   Yee, Chuen L ^b   Russo, Leo ^b   Bayney, Richard ^a   Thomas, Adrian P ^b   Klincewicz, Stephen L ^b  

^a JOHNSON AND JOHNSON   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adverse drug reactions; Decision making; Pharmacovigilance

Indexed keywords

CORRELATION ANALYSIS; DATA ANALYSIS; DATA BASE; DECISION MAKING; DECISION SUPPORT SYSTEM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EVALUATION; EVIDENCE BASED MEDICINE; MULTI ATTRIBUTE DECISION ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SIGNAL DETECTION; STATISTICAL MODEL; TECHNIQUE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA INTERPRETATION, STATISTICAL; DECISION SUPPORT TECHNIQUES; HUMANS; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS;

EID: 49749146762     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200831090-00001     Document Type: Review

References (23)

1. Bate A, Linquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998; 54: 315-21
2. Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10: 483-6
3. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 2002; 25 (6): 381-92
4. Eudravigilance Expert Working Group. Draft Guideline on the use of statistical signal detection methods in the Eudravigilance data analysis system. London: European Medicines Agency; 2006 Nov 16. EMEA/106464/2006
5. Purcell P, Barty S. Statistical techniques for signal generation: the Australian experience. Drug Saf 2002; 25 (6): 415-21
6. Almenoff J, Tonning A, Gould L, et al. Perspectives on the use of data mining in pharmacovigilance. Drug Saf 2005; 28 (11): 981-1007
7. Stahl M, Lindquist M, Edwards IR, et al. Introducing triage logic as a new strategy for the detection of signals in the WHO drug monitoring database. Pharmacoepidemiol Drug Saf 2004; 13: 355-63
8. Waller P, Lee E. Responding to drug safety issues. Pharmacoepidemiol Drug Saf 1999; 8 (7): 535-52
9. Clark JA. Algorithms. In: Mann RD, Andrews EB, editors. Pharmacovigilance. 1st ed. Chichester: John Wiley & Sons, 2002: 229-46
10. Holden WL, Juhaeri J, Dai W. Benefit-risk analysis: a proposal using quantitative methods. Pharmacoepidemiol Drug Saf 2003; 12: 611-6
11. Holden WL, Juhaeri J, Dai W. Benefit-risk analysis: examples using quantitative methods. Pharmacoepidemiol Drug Saf 2003; 12: 693-7
12. Waller P, Heeley E, Moseley J. Impact analysis of signals detected from spontaneous adverse drug reaction reporting data. Drug Saf 2005; 28 (1): 843-50
13. Heeley E, Waller P, Moseley J. Testing and implementing signal impact analysis in a regulatory setting: results of a pilot study. Drug Saf 2005; 28 (10): 901-6
14. Kirkwood CE. Strategic decision making: multiobjective decision analysis with spreadsheets. Belmont (CA): Duxbury Press, 1996
15. Keeney RL. Value-focused thinking: a path to creative decision-making. Cambridge (MA): Harvard University Press, 1996
16. Keeney RL, Raiffa H. Decisions with multiple objectives: preferences and value tradeoffs. Cambridge: Cambridge University Press, 1993
17. Yee CL, Klincewicz SL, Knight JF, et al. Practical considerations in developing an automated signaling program within a pharmacovigilance department. Drug Inf J 2004; 38: 293-300
18. Safety reporting requirements for human drug and biological products: proposed rule. Federal Register 2003 Mar 14; 67 (50) [online]. Available from URL: http://www.fda.gov/Cber/rules/safereport.htm [Accessed 2008 Jul 8]
19. Hogg R, Craig A. Introduction to mathematical statistics. 5th ed. Englewood Cliffs (NJ): Prentice Hall, 1994
20. Kendall MG. Rank correlation methods. 4th ed. London: Griffin, 1970
21. Siegel S, Castellan N. Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw-Hill, 1988
22. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; (33): 159-74
23. Landrum MB, Normand ST. Applying Bayesian ideas to the development of medical guidelines. Stat Med 1999; 18: 117-37